Aptevo Therapeutics Inc. (NASDAQ:APVO) ("Aptevo" or the "Company"), a clinical-stage biotechnology company focused on developing novel immune-oncology therapeutics based on its proprietary ADAPTIR ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
After hours: January 3 at 6:33:04 p.m. EST ...
At close: January 3 at 4:00:01 PM EST ...
After hours: 3 January at 6:33:04 pm GMT-5 ...
and 4-1BBx5T4 bispecific antibody ALG.APV-527 – being co-developed with Aptevo Therapeutics – which is in early clinical development. Last month, Alligator reported updated results from the ...
Analyst Douglas Tsao from H.C. Wainwright reiterated a Buy rating on Neumora Therapeutics, Inc. (NMRA – Research Report) and keeping the price target at $30.00. Discover the latest stocks ...
Maxim Group analyst Jason McCarthy maintained a Buy rating on Capricor Therapeutics (CAPR – Research Report) yesterday and set a price target of $25.00. Discover the latest stocks recommended by ...
SINGAPORE - CytoMed Therapeutics Limited (NASDAQ: GDTC), a biopharmaceutical company specializing in cell-based therapies for cancer treatment, has announced the commencement of a... ByInvesting ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback